2018
DOI: 10.2217/nnm-2018-0085
|View full text |Cite
|
Sign up to set email alerts
|

Nanoceria Suppresses Multiple Low Doses of Streptozotocin-Induced Type 1 Diabetes by Inhibition of Nrf2/NF-κB Pathway and Reduction of Apoptosis

Abstract: Considered together, our data establishes the antidiabetic potential of NC which may become a novel strategy to combat T1DM in the near future.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
50
0
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 66 publications
(54 citation statements)
references
References 46 publications
2
50
0
2
Order By: Relevance
“…Immunohistochemistry was performed on 5-μm thick sections after deparaffinisation as per an earlier described method (Khurana, Tekula, & Godugu, 2018). The sections were coincubated with primary rabbit polyclonal IgG antibodies (Nitrotyrosine, Nrf-2, IL-6, NF-κB) (Santa Cruz Biotechnologies, Santa Cruz, CA) (1:100 dilution) overnight, probed with secondary antibody.…”
Section: Immunohistochemistrymentioning
confidence: 99%
“…Immunohistochemistry was performed on 5-μm thick sections after deparaffinisation as per an earlier described method (Khurana, Tekula, & Godugu, 2018). The sections were coincubated with primary rabbit polyclonal IgG antibodies (Nitrotyrosine, Nrf-2, IL-6, NF-κB) (Santa Cruz Biotechnologies, Santa Cruz, CA) (1:100 dilution) overnight, probed with secondary antibody.…”
Section: Immunohistochemistrymentioning
confidence: 99%
“…In addition, detailed toxicological studies are necessary to decide the clinical future of this novel plant and its various active constituents as safety is a critical concern during clinical development of plant‐based medicines (Izzo, Hoon‐Kim, Radhakrishnan, & Williamson, ). In addition, physiological and biopharmaceutical parameters are often the bottleneck in the clinical translation of plant‐based medicines, which may be addressed by using various novel formulation‐based strategies (Bale, Khurana, Reddy, Singh, & Godugu, ; Godugu, Kumari, & Khurana, ; Khurana et al, ; Khurana, Saifi, & Godugu, ; Khurana, Tekula, Saifi, Venkatesh, & Godugu, ).…”
Section: Resultsmentioning
confidence: 99%
“…Immunohistochemistry was performed on 5 μm thick sections after deparaffinisation, as per our previously optimized protocol (Godugu, Doddapaneni, & Singh, ; Khurana, Tekula, & Godugu, ; Tekula et al, ). Sections were subjected to dehydration in graded alcohol followed by washing with Tris buffered saline (TBS) and incubation of the sections with proteinase‐K at 37°C for 20 min.…”
Section: Methodsmentioning
confidence: 99%
“…Histopathological examination of the mouse tissue sample (liver) from each study group was carried out to observe and compare the histological changes . Thin sections of 5 μm were used for H&E, picrosirius, and Masson's trichrome staining as per standard protocols .…”
Section: Methodsmentioning
confidence: 99%
“…Histopathological examination of the mouse tissue sample (liver) from each study group was carried out to observe and compare the histological changes. 25,26 Thin sections of 5 μm were used for H&E, picrosirius, and Masson's trichrome staining as per standard protocols. 27,28 Modified Knodell histology activity index grading was adopted for necroinflammatory scoring of H&E stained sections (no necrosis = 0, one or less necrotic foci per ×10 objective = 1, two to four foci per ×10 objective = 2, five to ten foci per ×10 objective = 3, >10 foci per ×10 objective = 4; no inflammation = 0, mild inflammation around some or all portal areas = 1, moderate inflammation = 2, marked inflammation = 3, marked inflammation around all portal areas = 4).…”
Section: Histopathological Analysismentioning
confidence: 99%